Postural Orthostatic Tachycardia Syndrome in COVID-19: A Contemporary Review of Mechanisms, Clinical Course and Management.
Vasc Health Risk Manag
; 19: 303-316, 2023.
Article
in English
| MEDLINE | ID: covidwho-2325162
ABSTRACT
The long-term implications of COVID-19 have garnered increasing interest in recent months, with Long-COVID impacting over 65 million individuals worldwide. Postural orthostatic tachycardia syndrome (POTS) has emerged as an important component of the Long-COVID umbrella, estimated to affect between 2 and 14% of survivors. POTS remains very challenging to diagnose and manage - this review aims to provide a brief overview of POTS as a whole and goes on to summarize the available literature pertaining to POTS in the setting of COVID-19. We provide a review of available clinical reports, outline proposed pathophysiological mechanisms and end with a brief note on management considerations.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Postural Orthostatic Tachycardia Syndrome
/
COVID-19
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Vasc Health Risk Manag
Journal subject:
Vascular Diseases
Year:
2023
Document Type:
Article
Affiliation country:
Vhrm.S380270
Similar
MEDLINE
...
LILACS
LIS